Literature DB >> 6477219

Pathologic laughing and crying treated with levodopa.

F Udaka, S Yamao, H Nagata, S Nakamura, M Kameyama.   

Abstract

Levodopa or amantadine hydrochloride was administered to 25 patients with pathologic laughing and/or crying. This symptom was markedly improved in ten cases, most of which were devoid of a cortical atrophy or a periventricular lucency in computed tomographic scan and also devoid of a severe dementia or a disturbance in activity of daily living. The concentration of homovanillic acid in the CSF of the patients was significantly decreased, whereas the concentration of 5-hydroxyindoleacetic acid remained within the normal limit. Because part of pathologic laughing and crying seems to be caused by the decreased function of the dopaminergic neuron, levodopa or amantadine is worth trying.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477219     DOI: 10.1001/archneur.1984.04050210093023

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

1.  Motor neurone disease.

Authors:  F H Norris
Journal:  BMJ       Date:  1992-02-22

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

3.  Drug treatment of emotionalism following brain damage.

Authors:  P Allman
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

Review 4.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.

Authors:  Xiaomeng Xu; Shifan Ma; Zhiwei Feng; Guanxing Hu; Lirong Wang; Xiang-Qun Xie
Journal:  J Mol Graph Model       Date:  2016-08-08       Impact factor: 2.518

Review 6.  Treatment of uncontrolled crying after stroke.

Authors:  G Andersen
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

7.  Emotionalism following brain damage: a complex phenomenon.

Authors:  P Allman; R A Hope; C G Fairburn
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

Review 8.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

9.  The causes and treatment of pseudobulbar affect in ischemic stroke.

Authors:  Preethi Balakrishnan; Howard Rosen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

10.  Central and peripheral effects of arecoline in patients with autonomic failure.

Authors:  R J Polinsky; R T Brown; M T Curras; S M Baser; C E Baucom; D R Hooper; A M Marini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.